jueves, 6 de septiembre de 2018

Patients in landmark genome-editing trial show improvement — but questions linger

Patients in landmark genome-editing trial show improvement — but questions linger

Daily Recap

STAT Plus: Patients in landmark genome-editing trial show improvement — but with questions over whether the therapy did the trick

By ADAM FEUERSTEIN


ALEX HOGAN/STAT
While patients showed improvement, Sangamo is downplaying some results from the study that are confounding and may give outsiders reason to be concerned.

No hay comentarios: